NO811571L - Analogifremgangsmaate for fremstilling av terapeutisk aktive 2(3h)-benzotiazolon-derivater - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive 2(3h)-benzotiazolon-derivaterInfo
- Publication number
- NO811571L NO811571L NO811571A NO811571A NO811571L NO 811571 L NO811571 L NO 811571L NO 811571 A NO811571 A NO 811571A NO 811571 A NO811571 A NO 811571A NO 811571 L NO811571 L NO 811571L
- Authority
- NO
- Norway
- Prior art keywords
- general formula
- group
- hydrogen atoms
- benzothiazolone
- mean
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 6
- 238000000034 method Methods 0.000 title claims description 11
- 230000001225 therapeutic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 32
- YEDUAINPPJYDJZ-UHFFFAOYSA-N 2-hydroxybenzothiazole Chemical class C1=CC=C2SC(O)=NC2=C1 YEDUAINPPJYDJZ-UHFFFAOYSA-N 0.000 claims abstract description 6
- -1 methylenedioxy group Chemical group 0.000 claims description 52
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 30
- 239000002904 solvent Substances 0.000 claims description 17
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 16
- 229910052801 chlorine Inorganic materials 0.000 claims description 15
- 239000000460 chlorine Substances 0.000 claims description 14
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 14
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 13
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 12
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 11
- 150000007513 acids Chemical class 0.000 claims description 10
- 239000007858 starting material Substances 0.000 claims description 10
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 9
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 9
- 239000011707 mineral Substances 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 7
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 7
- 235000019253 formic acid Nutrition 0.000 claims description 7
- LYSKATDZHMEORB-UHFFFAOYSA-N 4,6-dimethyl-3h-1,3-benzothiazol-2-one Chemical compound CC1=CC(C)=C2NC(=O)SC2=C1 LYSKATDZHMEORB-UHFFFAOYSA-N 0.000 claims description 6
- 239000012286 potassium permanganate Substances 0.000 claims description 6
- SOZONSXBIDNNRB-UHFFFAOYSA-N 6-methoxy-4-methyl-3h-1,3-benzothiazol-2-one Chemical compound COC1=CC(C)=C2NC(=O)SC2=C1 SOZONSXBIDNNRB-UHFFFAOYSA-N 0.000 claims description 5
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 5
- 229910052794 bromium Inorganic materials 0.000 claims description 5
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- YXIWHUQXZSMYRE-UHFFFAOYSA-N 1,3-benzothiazole-2-thiol Chemical compound C1=CC=C2SC(S)=NC2=C1 YXIWHUQXZSMYRE-UHFFFAOYSA-N 0.000 claims description 4
- CLYCLRFHPKKUBR-UHFFFAOYSA-N 6-amino-3h-1,3-benzothiazol-2-one Chemical compound NC1=CC=C2N=C(O)SC2=C1 CLYCLRFHPKKUBR-UHFFFAOYSA-N 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical class C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 claims description 4
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 4
- 150000003457 sulfones Chemical class 0.000 claims description 4
- BDHAESGKVWUFIA-UHFFFAOYSA-N 2-(2-nitrophenyl)ethanethioic s-acid Chemical class OC(=S)CC1=CC=CC=C1[N+]([O-])=O BDHAESGKVWUFIA-UHFFFAOYSA-N 0.000 claims description 3
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 3
- 239000003377 acid catalyst Substances 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 230000003647 oxidation Effects 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- 125000003626 1,2,4-triazol-1-yl group Chemical group [*]N1N=C([H])N=C1[H] 0.000 claims description 2
- 125000001401 1,2,4-triazol-4-yl group Chemical group N=1N=C([H])N([*])C=1[H] 0.000 claims description 2
- VRVRGVPWCUEOGV-UHFFFAOYSA-N 2-aminothiophenol Chemical compound NC1=CC=CC=C1S VRVRGVPWCUEOGV-UHFFFAOYSA-N 0.000 claims description 2
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims description 2
- PRMLFIZLUYYHCS-UHFFFAOYSA-N 3-acetyl-1,3-benzothiazol-2-one Chemical class C1=CC=C2SC(=O)N(C(=O)C)C2=C1 PRMLFIZLUYYHCS-UHFFFAOYSA-N 0.000 claims description 2
- KSHPCWFBCVSBBV-UHFFFAOYSA-N 7h-[1,3]dioxolo[4,5-f][1,3]benzothiazol-6-one Chemical compound C1=C2SC(=O)NC2=CC2=C1OCO2 KSHPCWFBCVSBBV-UHFFFAOYSA-N 0.000 claims description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 2
- 150000001447 alkali salts Chemical class 0.000 claims description 2
- 150000001351 alkyl iodides Chemical class 0.000 claims description 2
- 239000002585 base Substances 0.000 claims description 2
- 150000008050 dialkyl sulfates Chemical class 0.000 claims description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 238000007363 ring formation reaction Methods 0.000 claims description 2
- 125000004434 sulfur atom Chemical group 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 3
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 230000000202 analgesic effect Effects 0.000 abstract description 5
- 230000001754 anti-pyretic effect Effects 0.000 abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 90
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 51
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 47
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 34
- 239000000203 mixture Substances 0.000 description 34
- 239000000243 solution Substances 0.000 description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 27
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 24
- 238000006243 chemical reaction Methods 0.000 description 22
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- 239000002244 precipitate Substances 0.000 description 15
- 239000013078 crystal Substances 0.000 description 13
- 238000010992 reflux Methods 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 12
- 235000011121 sodium hydroxide Nutrition 0.000 description 12
- 238000001816 cooling Methods 0.000 description 11
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 238000002844 melting Methods 0.000 description 9
- 230000008018 melting Effects 0.000 description 9
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 9
- 238000000746 purification Methods 0.000 description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- 241000700159 Rattus Species 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- 238000009835 boiling Methods 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- BOKIESUSRKISCV-UHFFFAOYSA-N 4-methoxy-3h-1,3-benzothiazol-2-one Chemical compound COC1=CC=CC2=C1NC(=O)S2 BOKIESUSRKISCV-UHFFFAOYSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000000921 elemental analysis Methods 0.000 description 6
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 5
- IPRKHCSXTQTTGL-UHFFFAOYSA-N 3-acetyl-4-methoxy-1,3-benzothiazol-2-one Chemical compound COC1=CC=CC2=C1N(C(C)=O)C(=O)S2 IPRKHCSXTQTTGL-UHFFFAOYSA-N 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 229960000583 acetic acid Drugs 0.000 description 5
- 239000003513 alkali Substances 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 235000010755 mineral Nutrition 0.000 description 5
- 239000003208 petroleum Substances 0.000 description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- RNMYPTFMLLSPJI-UHFFFAOYSA-N 2-amino-4-chloro-5-methoxybenzenethiol Chemical compound COC1=CC(S)=C(N)C=C1Cl RNMYPTFMLLSPJI-UHFFFAOYSA-N 0.000 description 4
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 4
- HEIQAZAOOSKTDR-UHFFFAOYSA-N 5-chloro-6-methoxy-3h-1,3-benzothiazol-2-one Chemical compound C1=C(Cl)C(OC)=CC2=C1NC(=O)S2 HEIQAZAOOSKTDR-UHFFFAOYSA-N 0.000 description 4
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 230000007059 acute toxicity Effects 0.000 description 4
- 231100000403 acute toxicity Toxicity 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 229920000609 methyl cellulose Polymers 0.000 description 4
- 239000001923 methylcellulose Substances 0.000 description 4
- 235000010981 methylcellulose Nutrition 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- AWDBHOZBRXWRKS-UHFFFAOYSA-N tetrapotassium;iron(6+);hexacyanide Chemical compound [K+].[K+].[K+].[K+].[Fe+6].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] AWDBHOZBRXWRKS-UHFFFAOYSA-N 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 206010065390 Inflammatory pain Diseases 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- NDKBVBUGCNGSJJ-UHFFFAOYSA-M benzyltrimethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)CC1=CC=CC=C1 NDKBVBUGCNGSJJ-UHFFFAOYSA-M 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000013067 intermediate product Substances 0.000 description 3
- 235000010288 sodium nitrite Nutrition 0.000 description 3
- KKXFKDUISHGLNF-UHFFFAOYSA-N 2-amino-3-methoxybenzenethiol Chemical compound COC1=CC=CC(S)=C1N KKXFKDUISHGLNF-UHFFFAOYSA-N 0.000 description 2
- UHGULLIUJBCTEF-UHFFFAOYSA-N 2-aminobenzothiazole Chemical class C1=CC=C2SC(N)=NC2=C1 UHGULLIUJBCTEF-UHFFFAOYSA-N 0.000 description 2
- SLPKOCNNXGCCEK-UHFFFAOYSA-N 2-chloro-4,6-dimethoxy-1,3-benzothiazole Chemical compound COC1=CC(OC)=C2N=C(Cl)SC2=C1 SLPKOCNNXGCCEK-UHFFFAOYSA-N 0.000 description 2
- DGUINEVXAOBICO-UHFFFAOYSA-N 2-chloro-4,6-dimethyl-1,3-benzothiazole Chemical compound CC1=CC(C)=C2N=C(Cl)SC2=C1 DGUINEVXAOBICO-UHFFFAOYSA-N 0.000 description 2
- OAGNVMXTMNCVBA-UHFFFAOYSA-N 2-ethoxy-4,6-dimethyl-1,3-benzothiazole Chemical compound C1=C(C)C=C2SC(OCC)=NC2=C1C OAGNVMXTMNCVBA-UHFFFAOYSA-N 0.000 description 2
- CFPQMXOHJFGNNC-UHFFFAOYSA-N 2-ethoxy-4-methoxy-1,3-benzothiazole Chemical compound C1=CC=C2SC(OCC)=NC2=C1OC CFPQMXOHJFGNNC-UHFFFAOYSA-N 0.000 description 2
- GFEFOWOSGUPUFL-UHFFFAOYSA-N 2-ethoxy-5,6-dimethyl-1,3-benzothiazole Chemical compound CC1=C(C)C=C2SC(OCC)=NC2=C1 GFEFOWOSGUPUFL-UHFFFAOYSA-N 0.000 description 2
- LIRJJPPMKNTSOX-UHFFFAOYSA-N 2-ethoxy-5-methyl-1,3-benzothiazole Chemical compound CC1=CC=C2SC(OCC)=NC2=C1 LIRJJPPMKNTSOX-UHFFFAOYSA-N 0.000 description 2
- IHBITPPNLCMPBK-UHFFFAOYSA-N 2-ethoxy-6-methoxy-4-methyl-1,3-benzothiazole Chemical compound C1=C(OC)C=C2SC(OCC)=NC2=C1C IHBITPPNLCMPBK-UHFFFAOYSA-N 0.000 description 2
- FJUFBFYPFLRCFG-UHFFFAOYSA-N 2-ethoxy-7-methyl-1,3-benzothiazole Chemical compound C1=CC(C)=C2SC(OCC)=NC2=C1 FJUFBFYPFLRCFG-UHFFFAOYSA-N 0.000 description 2
- OAEINGHLJYOSDD-UHFFFAOYSA-N 4,6-dimethyl-2-methylsulfonyl-1,3-benzothiazole Chemical compound CC1=CC(C)=C2N=C(S(C)(=O)=O)SC2=C1 OAEINGHLJYOSDD-UHFFFAOYSA-N 0.000 description 2
- OZPDQKUEDLFNCO-UHFFFAOYSA-N 4,6-dimethyl-3h-1,3-benzothiazole-2-thione Chemical compound CC1=CC(C)=C2NC(=S)SC2=C1 OZPDQKUEDLFNCO-UHFFFAOYSA-N 0.000 description 2
- MVUTTXFFBOMSAY-UHFFFAOYSA-N 5-chloro-2-ethoxy-4-methoxy-1,3-benzothiazole Chemical compound ClC1=CC=C2SC(OCC)=NC2=C1OC MVUTTXFFBOMSAY-UHFFFAOYSA-N 0.000 description 2
- DCVMYBZKNLGTMT-UHFFFAOYSA-N 5-chloro-4-methoxy-3h-1,3-benzothiazol-2-one Chemical compound COC1=C(Cl)C=CC2=C1NC(=O)S2 DCVMYBZKNLGTMT-UHFFFAOYSA-N 0.000 description 2
- KKQDJOUTDGSIKF-UHFFFAOYSA-N 6-(dimethylamino)-3h-1,3-benzothiazol-2-one Chemical group CN(C)C1=CC=C2NC(=O)SC2=C1 KKQDJOUTDGSIKF-UHFFFAOYSA-N 0.000 description 2
- CPCWRGPJUDZREC-UHFFFAOYSA-N 7-methyl-3h-1,3-benzothiazol-2-one Chemical compound CC1=CC=CC2=C1SC(=O)N2 CPCWRGPJUDZREC-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- PHHZQJLADHRXLF-UHFFFAOYSA-N ethyl (2-amino-4-chloro-5-methoxyphenyl)sulfanylformate Chemical compound CCOC(=O)SC1=CC(OC)=C(Cl)C=C1N PHHZQJLADHRXLF-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 150000004679 hydroxides Chemical class 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 238000012417 linear regression Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000013421 nuclear magnetic resonance imaging Methods 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 235000011118 potassium hydroxide Nutrition 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- HAHHCJDOEAKYGQ-UHFFFAOYSA-N 2-amino-4,5-dimethylbenzenethiol Chemical compound CC1=CC(N)=C(S)C=C1C HAHHCJDOEAKYGQ-UHFFFAOYSA-N 0.000 description 1
- LSMMRJUHLKJNLR-UHFFFAOYSA-N 3-methyl-1,3-benzothiazol-2-one Chemical compound C1=CC=C2SC(=O)N(C)C2=C1 LSMMRJUHLKJNLR-UHFFFAOYSA-N 0.000 description 1
- RMPUUTICFPFVGC-UHFFFAOYSA-N 4,6-dimethyl-2-methylsulfanyl-1,3-benzothiazole Chemical compound C1=C(C)C=C2SC(SC)=NC2=C1C RMPUUTICFPFVGC-UHFFFAOYSA-N 0.000 description 1
- YEBCRAVYUWNFQT-UHFFFAOYSA-N 4-methoxy-1,3-benzothiazol-2-amine Chemical compound COC1=CC=CC2=C1N=C(N)S2 YEBCRAVYUWNFQT-UHFFFAOYSA-N 0.000 description 1
- NXFZVNGILJWVEL-UHFFFAOYSA-N 5,6-dimethyl-3h-1,3-benzothiazol-2-one Chemical compound C1=C(C)C(C)=CC2=C1SC(=O)N2 NXFZVNGILJWVEL-UHFFFAOYSA-N 0.000 description 1
- WSLXLABOEWJWJL-UHFFFAOYSA-N 5-chloro-6-methoxy-1,3-benzothiazol-2-amine Chemical compound C1=C(Cl)C(OC)=CC2=C1N=C(N)S2 WSLXLABOEWJWJL-UHFFFAOYSA-N 0.000 description 1
- COFWXEDIJNUQEW-UHFFFAOYSA-N 5-methoxy-6-methyl-1,3-benzothiazol-2-amine Chemical compound C1=C(C)C(OC)=CC2=C1SC(N)=N2 COFWXEDIJNUQEW-UHFFFAOYSA-N 0.000 description 1
- CHCYXBPFWCRKIT-UHFFFAOYSA-N 5-methyl-3h-1,3-benzothiazol-2-one Chemical compound CC1=CC=C2SC(=O)NC2=C1 CHCYXBPFWCRKIT-UHFFFAOYSA-N 0.000 description 1
- OTLGEWGTPFUDCJ-UHFFFAOYSA-N 6,7-dimethyl-3h-1,3-benzothiazol-2-one Chemical compound CC1=CC=C2NC(=O)SC2=C1C OTLGEWGTPFUDCJ-UHFFFAOYSA-N 0.000 description 1
- JFBKFFXBQWFVMU-UHFFFAOYSA-N 6-ethoxy-[1,3]dioxolo[4,5-f][1,3]benzothiazole Chemical compound C1=C2SC(OCC)=NC2=CC2=C1OCO2 JFBKFFXBQWFVMU-UHFFFAOYSA-N 0.000 description 1
- CVYMKCJLRXOQBG-UHFFFAOYSA-N 7-methyl-3h-1,3-benzothiazole-2-thione Chemical compound CC1=CC=CC2=C1SC(S)=N2 CVYMKCJLRXOQBG-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 238000005684 Liebig rearrangement reaction Methods 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000906446 Theraps Species 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 150000001448 anilines Chemical class 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 1
- 229910052601 baryte Inorganic materials 0.000 description 1
- 239000010428 baryte Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229950005499 carbon tetrachloride Drugs 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- JJWKPURADFRFRB-UHFFFAOYSA-N carbonyl sulfide Chemical compound O=C=S JJWKPURADFRFRB-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- AOGYCOYQMAVAFD-UHFFFAOYSA-N chlorocarbonic acid Chemical class OC(Cl)=O AOGYCOYQMAVAFD-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- 150000004292 cyclic ethers Chemical class 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- 150000001989 diazonium salts Chemical class 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 210000000548 hind-foot Anatomy 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- WLHVACSSRSCZGR-UHFFFAOYSA-N o-ethyl n-(3-methylphenyl)carbamothioate Chemical compound CCOC(=S)NC1=CC=CC(C)=C1 WLHVACSSRSCZGR-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19803017977 DE3017977A1 (de) | 1980-05-10 | 1980-05-10 | Neue substituierte 2(3h)-benzothiazolone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO811571L true NO811571L (no) | 1981-11-11 |
Family
ID=6102091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO811571A NO811571L (no) | 1980-05-10 | 1981-05-08 | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2(3h)-benzotiazolon-derivater |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0039818A1 (pt) |
| JP (1) | JPS577475A (pt) |
| AU (1) | AU7028181A (pt) |
| DE (1) | DE3017977A1 (pt) |
| DK (1) | DK203581A (pt) |
| ES (5) | ES502009A0 (pt) |
| FI (1) | FI811415L (pt) |
| GR (1) | GR75259B (pt) |
| IL (1) | IL62800A0 (pt) |
| NO (1) | NO811571L (pt) |
| NZ (1) | NZ197040A (pt) |
| PT (1) | PT72981B (pt) |
| ZA (1) | ZA813067B (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5968186A (ja) * | 1982-10-08 | 1984-04-18 | 松下電工株式会社 | フラツトケ−ブルの結線構造 |
| GB8320005D0 (en) * | 1983-07-25 | 1983-08-24 | Fujisawa Pharmaceutical Co | Benzothiazoline derivatives |
| KR850004744A (ko) * | 1983-12-17 | 1985-07-27 | 베트 셀, 좀머 | 6-에톡시-4-메틸-벤조티아졸-2(3h)-온의 제조방법 |
| DE3524067A1 (de) * | 1985-07-05 | 1987-01-08 | Boehringer Mannheim Gmbh | Neue benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte |
| US4835166A (en) * | 1986-06-09 | 1989-05-30 | Pfizer Inc. | Antiallergy and antiinflammatory agents |
| DK288287A (da) * | 1986-06-09 | 1987-12-10 | Pfizer | Heterocycliske forbindelser samt farmaceutiske praeparater til behandling af allergiske eller inflammatoriske tilstande |
| IL93473A0 (en) * | 1989-02-28 | 1990-11-29 | Pfizer | Antiinflammatory benzoxazolones |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL120102C (pt) * | 1955-07-20 | |||
| BR7204020D0 (pt) * | 1971-06-24 | 1973-11-01 | Hoechst Ag | Processo para a obtencao de benzoxazolonas-(2) e benzotiazolonas-(2) |
| DE2927352A1 (de) * | 1979-07-06 | 1981-02-05 | Thomae Gmbh Dr K | In 6-stellung substituierte benzothiazol-2(3h)-one enthaltende arzneimittel |
-
1980
- 1980-05-10 DE DE19803017977 patent/DE3017977A1/de not_active Withdrawn
-
1981
- 1981-04-27 EP EP81103152A patent/EP0039818A1/de not_active Withdrawn
- 1981-05-01 PT PT72981A patent/PT72981B/pt unknown
- 1981-05-06 IL IL62800A patent/IL62800A0/xx unknown
- 1981-05-07 DK DK203581A patent/DK203581A/da not_active Application Discontinuation
- 1981-05-08 GR GR64886A patent/GR75259B/el unknown
- 1981-05-08 JP JP6926081A patent/JPS577475A/ja active Pending
- 1981-05-08 ZA ZA00813067A patent/ZA813067B/xx unknown
- 1981-05-08 AU AU70281/81A patent/AU7028181A/en not_active Abandoned
- 1981-05-08 ES ES502009A patent/ES502009A0/es active Granted
- 1981-05-08 NZ NZ197040A patent/NZ197040A/xx unknown
- 1981-05-08 NO NO811571A patent/NO811571L/no unknown
- 1981-05-08 FI FI811415A patent/FI811415L/fi not_active Application Discontinuation
-
1982
- 1982-03-25 ES ES510788A patent/ES8303377A1/es not_active Expired
- 1982-03-25 ES ES510789A patent/ES510789A0/es active Granted
- 1982-03-25 ES ES510790A patent/ES510790A0/es active Granted
- 1982-03-25 ES ES510787A patent/ES510787A0/es active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| ES8303378A1 (es) | 1983-02-01 |
| NZ197040A (en) | 1983-12-16 |
| ES8206502A1 (es) | 1982-08-16 |
| PT72981A (de) | 1981-06-01 |
| AU7028181A (en) | 1981-11-19 |
| ES510788A0 (es) | 1983-02-01 |
| EP0039818A1 (de) | 1981-11-18 |
| ES502009A0 (es) | 1982-08-16 |
| DK203581A (da) | 1981-11-11 |
| ES8303376A1 (es) | 1983-02-01 |
| GR75259B (pt) | 1984-07-13 |
| ZA813067B (en) | 1983-01-26 |
| ES510789A0 (es) | 1983-02-01 |
| PT72981B (de) | 1983-02-01 |
| IL62800A0 (en) | 1981-07-31 |
| ES8303379A1 (es) | 1983-02-01 |
| ES510790A0 (es) | 1983-02-01 |
| ES8303377A1 (es) | 1983-02-01 |
| JPS577475A (en) | 1982-01-14 |
| DE3017977A1 (de) | 1981-11-19 |
| FI811415L (fi) | 1981-11-11 |
| ES510787A0 (es) | 1983-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4855298A (en) | 6-Halo-1,2,3,4-tetrahydroquinazoline-4-spiro-4-imidazolidine-2,2'5'-triones useful for the treatment and prophylaxis of diabetic complications | |
| NO150203B (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive 4-hydroksy-2h-1,2-benzotiazin-3-karboksamid-1,1-dioksyder | |
| CA3063111C (en) | Histone deacetylases (hdacs) inhibitors | |
| NZ201294A (en) | Imidazoquinoxaline derivatives | |
| US3399212A (en) | Benzimidazole ureas | |
| NO147879B (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-substituerte benzimidazoler | |
| NO811571L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2(3h)-benzotiazolon-derivater | |
| NO764039L (pt) | ||
| PL184860B1 (pl) | Chinoksaliny o własnościach leczniczychĆ zwłaszcza antywirusowychĆ sposób ich wytwarzania i środki lecznicze zawierające chinoksaliny jako substancje czynne | |
| EP1003724B1 (de) | Substituierte-chinolin-derivate mit antiviraler wirkung | |
| NO845169L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazol-derivater | |
| WO2005097755A2 (de) | Imidazolderivate als hemmer von tyrosinkinase | |
| JPH07242666A (ja) | 複素環化合物 | |
| JPH0673012A (ja) | ４−イミノキノリン、その製法およびその使用 | |
| PL101396B1 (pl) | Sposob wytwarzania estrow fenylowych kwasu 2-karboalkoksyaminobenzimidazolilo-5 /6/-sulfonowego | |
| US3244723A (en) | Certain 4-aminothiazole compounds and their preparation | |
| NO814468L (no) | Tiazolinderivater, fremgangsmaate til deres fremstilling, deres anvendelse samt farmasoeytiske preparater paa basis av disse forbindelser | |
| WO2011072779A1 (de) | Thiazolderivate zur behandlung von krankheiten wie krebs | |
| NO152843B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidopyrimidiner | |
| Schober et al. | Pyridazines with heteroatom substituents in positions 3 and 5. 6. SN reactions in position 5 of 2‐aryl‐5‐hydroxypyridazin‐3 (2H)‐ones | |
| NO148490B (no) | Analogifremgangsmaate for fremstilling av medisinsk virksomme 1,2-tiazino(5,6-b)indoler | |
| EP0039440B1 (de) | Substituierte Benzothiazol-2(3H)-one enthaltende Arzneimittel | |
| KR810001980B1 (ko) | 2, 5-디히드로-1, 2-티아지노 [5, 6-b] 인돌-3-카복사미드-1, 1-디옥사이드의 제조방법 | |
| US2537870A (en) | 2-haloquinoxaline and process for preparing same | |
| KR790000984B1 (ko) | 8α-에르골린 유도체의 제조방법 |